浏览标题索引

标题 文件
卷 3, 编号 1 (2001) Novoe v terapii raka molochnoy zhelezy: neoad\"yuvantnaya gormonoterapiya
Semiglazov V., Semiglazov V., Ivanov V., Bershteyn L., Tsyrlina E., Zhil'tsova E., Arzumanov A., Nurgaziev K.
卷 23, 编号 2 (2021) Isatuximab, a novel anti-CD38 monoclonal antibody in the treatment of multiple myeloma: efficacy and safety PDF
(Rus)
Zatolochina K., Zyryanov S., Ushkalova E.
卷 4, 编号 3 (2002) Novoe napravlenie v lechenii khronicheskogo bolevogo sindroma u onkologicheskikh bol'nykh
Isakova M., Pavlova Z., Bryuzgin V.
卷 6, 编号 2 (2004) Novye aktsenty v endokrinnoy terapii raka molochnoy zhelezy
Makarenko N.
卷 16, 编号 1 (2014) New aspects of the first-line chemotherapy in colorectal cancer
Artamonova E.
卷 20, 编号 2 (2018) New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors PDF
(Rus)
Laktionov K., Reutova E., Nelyubina L., Pitkevich M., Okruzhnova M., Ardzinba M., Yudin D., Demidova I., Zaretsky A.
卷 3, 编号 2 (2001) Novye vozmozhnosti v terapii zrelokletochnykh nekhodzhkinskikh limfom: preparat "Mabtera" - nastoyashchee i budushchee
Poddubnaya I., Osmanov D., Probatova N., Tupitsin N., Kruglova G., Kuril'nikov A., Sholokhova E., Manzyuk L., Borodkina A., Shirin A., Unukova E., Zeynalova P., Byalik T., Sorokin E., Petrov O.
卷 22, 编号 2 (2020) New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas PDF
(Rus)
Poddubnaya I., Ptushkin V., Belousova I., Gorenkova L., Kaplanov K., Karamova A., Kovrigina A., Kolomeitsev O., Konstantinova T., Kokhan M., Pospelova T.
卷 14, 编号 2 (2012) Novye vozmozhnosti targetnoy terapii v onkodermatologii
- -.
卷 10, 编号 1 (2008) Novye vozmozhnosti targetnoy terapii neyropaticheskoy boli v onkologii
Abuzarova G., Prokhorov B., Sokolenov A., Shakhnovich E.
卷 13, 编号 2 (2011) Novye vozmozhnosti targetnoy terapiirasprostranennogo raka pochki
- -.
卷 26, 编号 3 (2024) New therapies for hormone-positive HER2-negative metastatic breast cancer with AKT signaling alterations: the Expert Panel Decision PDF
(Rus)
Editorial B.
卷 27, 编号 2 (2025) Novel therapies for the metastatic HER2-positive breast cancer with metastases in the central nervous system: a clinical case PDF
(Rus)
Radyukova I., Rats N.
卷 18, 编号 2 (2016) New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer PDF
(Rus)
Semiglazova T., Klyuge V., Semiglazov V., Teletaeva G., Krivorotko P., Dashyan G., Paltuev R., Tkachenko E., Donskikh R., Semiglazov V.
卷 15, 编号 2 (2013) New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
Artamonova E., Manzyuk L.
卷 3, 编号 3 (2001) Novye vozmozhnosti endokrinnoy terapii raka molochnoy zhelezy
Makarenko N., Poddubnaya I.
卷 13, 编号 3 (2011) Novye vozmozhnostiv lechenii raka pryamoy kishki
Artamonova E.
卷 16, 编号 2 (2014) New horizons in skin malignancies treatment
Gamaunov S.
卷 9, 编号 1 (2007) Novye gorizonty immunoterapii nekhodzhkinskikh limfom iz kletok zony mantii
Poddubnaya I.
卷 3, 编号 4 (2001) Novye immunologicheskie markery (CD71 , LU-BCRU-G7), vzaimosvyazannye s prognozom raka molochnoy zhelezy
Tupitsyn N., Letyagin V., Panichenko A., Vasil'ev M., Shinkarev S., Artamonova E., Ognerubov N., Ermilova V., Ryazantseva S.
卷 13, 编号 3 (2011) Novye lekarstvennye preparatyv terapii raka predstatel'noyzhelezy, rezistentnogo k kastratsii
Petrov S., Nosov A., Vorob'ev N.
卷 13, 编号 4 (2011) Novye rekomendatsii EORTC po primeneniyugranulotsitarno-koloniestimuliruyushchegofaktora (G-KSF) dlya snizheniya riskarazvitiya febril'noy neytropenii (FN)u vzroslykh patsientov s limfomamii solidnymi opukholyami.Algoritm opredeleniya riska razvitiya FNi primenenie G-KSF
- -.
卷 13, 编号 2 (2011) Novye strategii terapii zlokachestvennykhlimfoproliferativnykh zabolevaniyobsuzhdalis' v Sankt-Peterburgena forume onkogematologov
- -.
卷 4, 编号 1 (2002) Novyy vek - novye vozmozhnosti khimioterapii: temodal v lechenii zlokachestvennykh opukholey
Poddubnaya I.
卷 14, 编号 3 (2012) Novyy vzglyad na biologicheskie osobennosti pervichnoy ekstranodal'noy diffuznoy V-krupnokletochnoy limfomy
Subortseva I., Kovrigina A., Korobko I., Poddubnaya I.
卷 5, 编号 3 (2003) Novyy vzglyad na neoad\"yuvantnuyu khimioterapiyu raka molochnoy zhelezy (rol' navel'bina)
Semiglazov V., Arzumanov A., Bozhok A., Paltuev R., Topuzov E., Semiglazov V., Klettsel' A., Nurgaziev K., Ivanova O., Petrovskiy S.
卷 10, 编号 4 (2008) Novyy shag k prodleniyu zhizni bol'nykh metastaticheskim rakom pecheni
- -.
卷 20, 编号 1 (2018) Nosological structure of patients in oncohematology department at the Loginov Moscow Clinical Scientific Center for 2016 year PDF
(Rus)
Pivnik A., Dudina G., Petrenko A., Tumanova M., Stuklov N., Leyghton R., Nikerova L., Dubnitskaya M., Mukhin O., Kremneva N., Fedorova V.
卷 25, 编号 3 (2023) Nutritional support in oncology: the place of parenteral nutrition (literature review) PDF
(Rus)
Pasechnik I., Skobelev E., Boldyreva T.
卷 24, 编号 1 (2022) Nutritional support in the perioperative period of treatment of cancer patients: Retrospective cohort study PDF
(Rus)
Gameeva E., Stepanovna A., Khoronenko V., Gridnev O., Sviridov S., Shestopalov A.
卷 25, 编号 2 (2023) Nutritional support for primary patients with esophageal cancer (analytical review) PDF
(Rus)
Obukhova O., Kurmukov I., Abu-Khaidar O.
卷 18, 编号 4 (2016) Nutritional status of children with cancer and hematological malignancies during treatment in FSBI Federal Scientific Clinical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev (screening results)
Vasilyeva E., Vashura A., Litvinov D.
卷 24, 编号 3 (2022) Multidisciplinary interaction of Russian professional communities in oncology PDF
(Rus)
Khatkov I., Andreyashkina I., Zelenova E., Trotsenko I.
卷 12, 编号 3 (2010) Obzor konferentsii ekspertovv oblasti lekarstvennoy terapii rakapochki «Novye vozmozhnosti v terapiimetastaticheskogo raka pochki»
Volkova L.
卷 17, 编号 4 (2015) Review of the Event: The role of local biosimilar drugs and original biological drugs in modern cancer treatment
- -.
卷 14, 编号 4 (2012) Obrazovatel'nye meropriyatiyav oblasti abdominal'noy onkologii
- -.
卷 7, 编号 2 (2005) Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastey golovnogo mozga
Karakhan V., Aleshin V., Fu R., Krat V.
卷 9, 编号 3 (2007) Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy
Khvastunov R., Kireev A., Nikol'skiy I., Suvorov V.
卷 24, 编号 4 (2022) Oxycodone for cancer-related pain in adults (Russian Translation of Cochrane Plain Language Summary (PLS)) PDF
(Rus)
Bayazitova R.
卷 20, 编号 3 (2018) Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients PDF
(Rus)
Artamonova E., Kovalenko E., Snegovoy A., Aksarin A., Anciferova T., Belonogov A., Bilan E., Bilenko S., Varvus I., Gorkovenko E., Enikeev R., Ermolaeva A., Kramskaya L., Kononenko I., Pechenyy A., Safina S., Chupriyanova T., Chuhua G., Shemyakina A., Shikina E.
卷 19, 编号 3 (2017) Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer PDF
(Rus)
Khokhlova S.
卷 7, 编号 1 (2005) Opioidnyy anal'getik tsentral'nogo deystviya tramadola gidrokhlorid (tramal) pri lechenii khronicheskoy boli u onkologicheskikh bol'nykh
Isakova M., Pavlova Z., Bryuzgin V.
卷 14, 编号 1 (2012) Opisanie klinicheskikhsluchaev primeneniya kombinatsiys lapatinibom v lecheniiHER2-pozitivnogo rasprostranennogoraka molochnoy zhelezy
Bolotina L., Kramskaya L., Smirnova I., Zharikova I., Aminov G.
卷 13, 编号 1 (2011) Opredelenie HER2/neu-statusa po gistologicheskomu materialu -est' li prostranstvo dlya diskussii?
Borbat A., Tkachenko E., Pozharisskiy K.
卷 26, 编号 1 (2024) Detection of mutations in the BRAF in patients with melanoma in routine clinical practice: Survey results PDF
(Rus)
Orlova K., Demidov L.
卷 23, 编号 2 (2021) The identification of tumor-infiltrating lymphocytes in patients with stomach cancer PDF
(Rus)
Khakimova G., Bozhchenko Y., Zabotina T., Tryakin A.
卷 25, 编号 1 (2023) Determination of sentinel lymph nodes in gynecological cancer using the radiopharmaceutical Sentiscan. A case series PDF
(Rus)
Shevchuk A., Krylov A., Knyazev R., Afanasieva K.
卷 20, 编号 2 (2018) Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved? PDF
(Rus)
Zhukova L., Ganshina I., Khatkova E., Tikhomirova T., Kondratyeva O.
卷 18, 编号 1 (2016) The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options PDF
(Rus)
Artamonova E., Manzyuk L.
卷 6, 编号 2 (2004) Optimizatsiya kombinirovannogo lecheniya bol'nykh mestno-rasprostranennym rakom gortanoglotki
Madzhidov M.
卷 12, 编号 4 (2010) Optimizatsiya metodov lecheniyakhronicheskogo bolevogo sindroma u bol'nykhs metastazami v kosti disseminirovannogoraka molochnoy zhelezy
Kogoniya, L., Mos'kin V.
卷 22, 编号 4 (2020) Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor PDF
(Rus)
Ganshina I., Ivanova K., Lubennikova E., Arkhipov A., Zhukova L.
卷 14, 编号 1 (2012) Opukhol' Abrikosova:porazhenie legkikh u rebenka 4 let
Seroklinov V., Kozhevnikov V., Chursin A., Bylina E., Logvinova T., Drachev V., Starodubtsev E., Mizernitskiy Y.
卷 12, 编号 1 (2010) Opyt GNTs RAMN po primeneniyunilotiniba (Tasigna) u bol'nykhv khronicheskoy faze khronicheskogomieloleykoza pri neudache terapiiimatinibom
Gusarova G., Turkina A., Domracheva E., Tikhonova L., Egorova M., Kolosheynova T., Stakhina O., Nemchenko I., Vakhrusheva M., Chelysheva E., Zakharova E., Goryacheva S., Sokolova M., Kuznetsov S., Afanas'eva N., Khoroshko N.
卷 13, 编号 1 (2011) Opyt dlitel'nogo primeneniya kombinatsii kapetsitabina, lapatiniba i trastuzumabapri HER-2-pozitivnom metastaticheskom rake molochnoy zhelezy. Opisanie klinicheskogo sluchaya
Zhukova L., Okruzhnova M., Lubennikova E., Zeynalova K.
卷 26, 编号 4 (2024) Experience of Next-Generation Sequencing in urothelial carcinoma specimens with panel for 523 genes PDF
(Rus)
Gridneva Y., Khmelkova D., Volkova M., Blagodatskikh K., Zheludkevich A., Semenova A., Veshchevailov A., Babkina A., Bondarev S., Galkin V.
卷 16, 编号 3 (2014) Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer
Gridneva Y., Matveev V., Kupchan D., Kalinin S., Peters M.
卷 12, 编号 1 (2010) Opyt lecheniya kapetsitabinomi trastuzumabom metastaticheskogoporazheniya golovnogo mozga pri rakemolochnoy zhelezy s giperekspressieyHer-2/neu
Naskhletashvili D., Chmutin G., Karakhan V., Aleshin V., Fu R., Moskvina E., Belov D., Luk'yanchenko A., Ivanova E.
卷 15, 编号 2 (2013) Experience with Hyposalix spray treatment for xerostomia
Afanasyev V., Titova O., Ordashev K., Ugurchiev Y.
卷 24, 编号 2 (2022) Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report PDF
(Rus)
Gushchina E., Vernyuk M., Chervontseva A., Cherkashina I., Khayrullina L., Lunin V., Fedenko A.
卷 24, 编号 3 (2022) Experience in the treatment of radioinduced angiosarcoma of the breast in a patient with primary multiple lesions of the breast and bladder. Case report PDF
(Rus)
Semenov E., Gasymly D., Zyuzyukina A., Zukov R.
卷 12, 编号 1 (2010) Opyt lecheniya stromal'nykh opukholeyzheludochno-kishechnogo traktav Chelyabinskoy oblasti
Antonov A., Nadvikova E., Vazhenin A.
卷 16, 编号 4 (2014) Radiation treatment of the primary vulvar Pagetʼs disease: case report
Razumova E., Kizhaev Y., Ukolova E.
卷 25, 编号 3 (2023) Experience in organizing nutritional support in cancer patients at the Tsyb Medical Radiological Research Centre PDF
(Rus)
Potapov A., Аgababyan T., Dorozhkin A., Pimonova I., Nevolskikh A., Ivanov S., Kaprin A.
卷 5, 编号 1 (2003) Opyt primeneniya abitaksela™ v lechenii solidnykh opukholey
Blyumenberg A., Gutorov S., Topchieva S., Gorbunova V., Lichinitser M.
卷 12, 编号 3 (2010) Opyt primeneniya Avastina (bevatsizumaba)v sochetanii s khimioterapiey v lecheniirasprostranennykh form nemelkokletochnogoraka legkogo v otdelenii torakal'noyonkologii
Orlov S., Stel'makh L., Lozhkina A., Poltoratskiy A.
卷 14, 编号 3 (2012) Opyt primeneniya bendamustina u patsientov s retsidivom khronicheskogo limfoleykoza v rezhime monoterapii v ambulatornykh usloviyakh
Ivashchenko A.
卷 15, 编号 3 (2013) Opyt primeneniya Votrienta v kombinirovannom lechenii redkikh mestno-rasprostranennykh sarkom myagkikh tkaney vysokoy stepeni zlokachestvennosti
Zubarev A., Kuril'chik A., Starodubtsev A., Ivanov V.
卷 8, 编号 1 (2006) Opyt primeneniya vysokodoznoy khimioterapii pri retsidiviruyushchem techenii i refrakternykh formakh limfomy Khodzhkina (retrospektivnyy analiz dannykh chetyrekh transplantatsionnykh tsentrov Respubliki Belarus', Rossiyskoy Federatsii i Ukrainy)
Zhukov N., Uss A., Afanas'ev B., Karamanesht E., Ptushkin V.
卷 13, 编号 1 (2011) Opyt primeneniya gefitiniba v lechenii nemelkokletochnogo raka legkikh v Orlovskoy oblasti
Golubenko R., Gromov G., Vishnevskiy V.
卷 14, 编号 4 (2012) Opyt primeneniya kapetsitabina v neoad\"yuvantnoy khimioterapii raka molochnoy zhelezy
Slonimskaya E., Tarabanovskaya N., Bragina O., Garbukov E., Doroshenko A., Kokorina Y., Zav'yalova M.
卷 11, 编号 1 (2009) Opyt primeneniya kapetsitabinau bol'nykh rakom molochnoy zhelezy s metastazami v golovnoy mozg
Naskhletashvili D., Chmutin G., Karakhan V., Aleshin V., Fu R., Belov D., Ivanova E.
卷 25, 编号 3 (2023) Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis PDF
(Rus)
Lyadova M., Fedorinov D., Kuzmina E., Antonova T., Sokolskaya V.
卷 17, 编号 3 (2015) Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors
Markovich A., Kuzminov A., Orel N., Odintsova A., Emelyanova G., Gorbunova V.
卷 19, 编号 2 (2017) Experience of the usage intraoperative radiation therapy after neoadjuvant systemic drug treatment and sentinel lymph node biopsy in breast cancer patients with clinical stage T2N0M0 PDF
(Rus)
Manikhas A., Grinev I., Oganesian A., Chikrizov S., Manikhas G.
卷 19, 编号 2 (2017) Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer PDF
(Rus)
Kit O., Vladimirova L., Abramova N., Storozhakova A., Popova I., Tikhanovskaya N., Lyaynova A., Ryadinskaya L.
卷 24, 编号 2 (2022) Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study PDF
(Rus)
Sultanbaev A., Menshikov K., Musin S., Nasretdinov A., Fatikhova A., Izmailov A., Lipatov O., Ayupov R., Sultanbaeva N., Menshikova I., Serebrennikov G.
卷 9, 编号 2 (2007) Opyt primeneniya preparata Vero-kladribin u bol'nykh volosatokletochnym leykozom
Al'-Radi L., Moiseeva T., Kravchenko S.
卷 25, 编号 3 (2023) Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study PDF
(Rus)
Evdokimov V., Bloshchinenko A., Abolmasov A., Vilensky A., Laskov M.
卷 10, 编号 2 (2008) Opyt primeneniya preparata Eloksatin pri kolorektal'nom rake
Voznyy E., Popov A., Astrakhankina T., Grishunenkova E., Polyanskaya E.
卷 26, 编号 1 (2024) Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study PDF
(Rus)
Levashov A., Zagidullina S., Valiev T., Stroganova A., Khochenkov D., Grigorenko V., Mikhaylova E., Tyurina E., Ryzhova M., Horielyshev S., Kadirov S., Polyakov V.
卷 7, 编号 1 (2005) Opyt primeneniya Regional'noy programmy v g. Krasnodare
Mitashok I.
卷 19, 编号 3 (2017) The experience with the application of first-line chemotherapy regimen with EDP-M (etoposide + doxorubicin + cisplatin + mitotane) in patients with advanced adrenocortical carcinoma in the Russian Federation PDF
(Rus)
Kolomeytseva A., Yemelyanova G., Gorbunova V., Orel N., Perevodchikova N., Bokhyan V., Fedenko A.
卷 4, 编号 3 (2002) Opyt primeneniya taksola v khimioterapii ploskokletochnogo raka golovy i shei
Podvyaznikov S., Byakhov M.
卷 8, 编号 1 (2006) Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy
Samoylenko V., Gorbunova V., Koshelev M., Yurashko K.
卷 16, 编号 3 (2014) Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial
Ahmetzanov F., Ahmetzanova F.
卷 14, 编号 4 (2012) Opyt provedeniya nablyudatel'nykhprogramm v abdominal'noy onkologii
- -.
卷 18, 编号 3 (2016) Experience in prevention of neutropenia in patients with disseminated soft tissue sarcomas receiving polychemotherapy PDF
(Rus)
Vladimirova L., Mitashok I., Snezhko T., Samaneva N., Storozhakova A., Kornilova I.
卷 8, 编号 2 (2006) Opyt profilakticheskogo primeneniya rekombinantnogo faktora Vila dlya umen'sheniya intraoperatsionnykh krovotecheniy u onkologicheskikh bol'nykh
Barkagan Z., Khodorenko S., Mamaev A., Nazarov A., Mamaeva I., Tsyvkina L., Rossokha A.
卷 23, 编号 2 (2021) Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period PDF
(Rus)
Bukharov A., Derzhavin V., Yadrina A., Erin D.
卷 3, 编号 2 (2001) Opyt trakheobronkhoplasticheskikh operatsiy pri opukholyakh legkikh i trakhei
Novikov E., Aminodov S., Solov'ev V., Smirnov A.
卷 14, 编号 2 (2012) Opyt uspeshnogo lecheniya HER2-pozitivnogo metastaticheskogo raka zheludka
Gamayunov S., Slugarev V., Ter-Ovanesov M., Zakharova E.
卷 25, 编号 2 (2023) Experience of surgical treatment of hemangioma of the spleen. A clinical case PDF
(Rus)
Chekini A., Novikov D., Avturkhanov T., Mkrtumyan R., Novikova A.
卷 5, 编号 3 (2003) Oral'nyy vepezid v lechenii retsidivov i platinorezistentnykh form raka yaichnikov (opyt primeneniya)
Makhnova E.
卷 5, 编号 1 (2003) Organizatsionno-metodicheskie aspekty realizatsii Regional'noy programmy lecheniya mestno-rasprostranennogo i metastaticheskogo raka molochno y zhelezy s ispol'zovaniem rezhima dotsetaksel/doksorubitsin
Podregul'skiy K., Poddubnaya I.
卷 3, 编号 1 (2001) Organosokhranyayushchee lechenie - perspektivnoe napravlenie razvitiya onkopediatrii XXI veka
Durnov L., Sharoev T., Polyakov V., Ivanova N., Lebedev V., Pashkov Y., Bondar' I., Belkina B., Boychenko E.
卷 12, 编号 1 (2010) Original'naya kombinatsiyaFtorafur® + vinorelbinv lechenii raka molochnoy zhelezy:pervye rezul'taty
Manzyuk L., Artamonova E., Satirova E., Alatortseva E.
卷 8, 编号 3 (2006) Ortopedicheskaya reabilitatsiya onkologicheskikh bol'nykh s defektami verkhney chelyusti
Chuykov M., Matyakin E., Azizyan R., Akhundov A., Mudunov A., Podvyaznikov O., Fedotov N., Chuchkov M., Agapov V.
卷 21, 编号 3 (2019) Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer
Reutova E., Laktionov K., Iudin D., Neliubina L., Gorokhova G., Egorova A.
卷 24, 编号 1 (2022) Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report PDF
(Rus)
Orlov S., Baldin P., Diuzeva N., Krechetova A., Mordovskiy A., Moskovchenko A., Musaeva N., Romanchuk O.
卷 7, 编号 2 (2005) Osnovnye aspekty primeneniya bisfosfonatov v onkologii
Kondrat'eva A.
卷 15, 编号 4 (2013) The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.
卷 5, 编号 2 (2003) Osnovnye napravleniya sovremennoy luchevoy terapii zlokachestvennykh opukholey
Kondrat'eva A.
卷 5, 编号 4 (2003) Osnovnye problemy optimizatsii okazaniya onkologicheskoy pomoshchi naseleniyu( Yakutsk, 1992 - 2002 gg.)
Poddubnaya I., Aksel' E., Ivanov P., Ivanova R., Kipriyanova N., Afanas'eva L.
卷 22, 编号 3 (2020) Features of management of oncohematological patients in the context of the COVID-19 pandemic PDF
(Rus)
Poddubnaya I., Tumian G., Trofimova O., Babicheva L., Bariakh E., Poliakov A.
卷 22, 编号 2 (2020) Cancer patient management during the COVID-19 pandemic Training module. Version 2 from 30.04.2020 PDF
(Rus)
Poddubnaya I., Sychev D., Abuzarova G., Allakhverdiev A., Arkhiri P., Babicheva L., Baranova M., Volkova M., Ignatova A., Kashurnikov A., Kniazev R., Kolyadina I., Komarov I., Kriukov A., Levitskaia N., Liadov V., Malikhova O., Nered S., Orel N., Podviaznikov S., Sagaidak I., Sarmanaeva R., Stilidi I., Trofimova O., Tumian G., Kharitonova T.
卷 19, 编号 4 (2017) Principles of diagnosis and surgical treatment of patients with retroperitoneal schwannomas PDF
(Rus)
Bugaev V., Nikulin M., Melikov S.
卷 8, 编号 3 (2006) Osobennosti kliniko-morfologicheskikh kharakteristik i lecheniya retsidiva raka yaichnikov IV stadii
Mel'ko A., Ushakov I., Kira E., Shamkina V., Gaytukieva R.
卷 8, 编号 4 (2006) Osobennosti klinicheskogo techeniya i prognoz bol'nykh nekhodzhkinskoy limfomoy s pervichnoy lokalizatsiey v yaichke
Tumyan G., Kovrigina A., Timofeeva O., Probatova N., Sholokhova E., Tupitsyn N., Poddubnaya I., Osmanov D.
卷 17, 编号 3 (2015) Osobennosti korrektsii naibolee chastykh nezhelatel'nykh yavleniy na fone primeneniya ingibitorov BRAF i MEK
Samoylenko I.
卷 4, 编号 4 (2002) Osobennosti lecheniya bol'noy neorgannoy pleomorfnoy liposarkomoy
Blyumenberg A., Kuznetsov V., Gorbunova V., Mikhina Z., Borisov V., Gubin A., Poddubnyy B., Petrovichev N., Kiselevskiy M., Zakharova T., Kireev A., Vakurova E., Rotin D.
卷 18, 编号 5 (2016) Characteristics of approach to the treatment of chronic pain in terminal cancer patients
Nevzorova D., Ibragimov A., Bakunina E.
卷 19, 编号 1 (2017) The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer PDF
(Rus)
Demidova I.
卷 23, 编号 4 (2021) Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III PDF
(Rus)
Morozov D., Kolyadina I., Poddubnaya I., Ganshina I., Khokhlova S., Kоmetova V., Rodionov V.
卷 9, 编号 3 (2007) Osobennosti profilaktiki posleoperatsionnykh tromboembolicheskikh oslozhneniy u patsientov so zlokachestvennymi zabolevaniyami
Pashanov E., Zamyatin M., Stoyko Y., Rumyantsev A.
卷 17, 编号 3 (2015) Osobennosti profilya toksichnosti ingibitorov BRAF i MEK
Protsenko S.
卷 16, 编号 4 (2014) Features of development of metachronous and synchronous tumors in the population of Belgorod region associated with the consequences of the Chernobyl accident
Kovalenko B., Golivets T., Podvyaznikov S.
卷 10, 编号 3 (2008) Osobennosti reproduktivnoy funktsii u zhenshchin s onkogematologicheskimi zabolevaniyami
Shmakov R., Polushkina E.
卷 5, 编号 2 (2003) Osobennosti serdechno-dykhatel'nogo sinkhronizma u zhenshchin s razlichnym tonusom vegetativnoy nervnoy sistemy na etape postanovki onkologicheskogo diagnoza
Arkad'eva T., Selyan N.
卷 18, 编号 1 (2016) Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy PDF
(Rus)
Kolyadina I., Poddubnaya I., Pavlikova O., Komov D.
卷 13, 编号 3 (2011) Osteopontin, CD55:prognosticheskie faktory riskapri rake molochnoy zhelezy
Guzieva Z., Poddubnaya I., Vishnevskaya Y., Makarenko N., Sytenkova K.
卷 24, 编号 1 (2022) From the editor-in-chief of the journal "Modern Oncology" Academician of the Russian Academy of Sciences I.V. Poddubnaya PDF
(Rus)
Poddubnaya I.
卷 10, 编号 3 (2008) Ot glavnogo redaktora Uvazhaemye kollegi!
Poddubnaya I.
卷 18, 编号 1 (2016) Long-term effects of pediatric cancer therapy: 35-year clinical experience PDF
(Rus)
Zaeva G., Valiev T., Gavrilenko T., Moiseenko E., Medvedovskaya E., Mikhailova S., Sinyagina Y.
卷 11, 编号 3 (2009) Otdalennye rezul'taty khirurgicheskogo lecheniya gastrointestinal'nykh stromal'nykh opukholey zheludochno-kishechnogo trakta
Istomin Y., Evdokimov M.
卷 7, 编号 3 (2005) Otkrytaya mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti kombinirovannoy terapii myustoforanom, tsisplatinom, tamoksifenom patsientov s disseminirovannoy zlokachestvennoy melanomoy
Konstantinova M., Gershanovich M., Akimov M., Nosov D., Bogdanova N.
卷 3, 编号 1 (2001) Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov)
Poddubnaya I., Khasanov R., Ruchkin V., Lazarev A., Byakhov M., Vtoraya O., Yurchenko V.
卷 27, 编号 1 (2025) Long-term aesthetic outcomes of reconstructive surgeries with endoprosthetics for breast cancer: A review PDF
(Rus)
Khomidi U., Vlasova M., Saribekyan E., Zikiryakhodzhaev A., Khakimova S., Khakimova G., Kodzoeva D.
卷 18, 编号 2 (2016) Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study PDF
(Rus)
Ignatova E., Burdaeva O., Kopp M., Kotiv B., Udovitsa D., Stroiakovskii D., Alekseev S., Sheveleva L., Khorinko A., Shapovalova I., Moiseenko V., Ivanov R.
卷 19, 编号 3 (2017) Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer PDF
(Rus)
Nenakhova Y., Lyadov V., Poddubnaya I.
卷 23, 编号 1 (2021) Assessment and correction of the geriatric status of patients with metastatic colorectal cancer during the first-line systemic therapy PDF
(Rus)
Alekseeva Y., Semiglazova T., Sharashenidze S., Tkachenko E., Kasparov B., Brish N., Teletaeva G., Filatova L., Sluzhev M., Semiglazov V., Protsenko S., Belyaev A.
卷 25, 编号 3 (2023) Clinical and economic benefits of parenteral iron carboxymaltosate in patients with gynecological cancers: A retrospective observational study PDF
(Rus)
Saevets V., Shamanova A.
卷 26, 编号 2 (2024) Clinical benefits of parenteral iron carboxymaltose in patients with colorectal cancer: a retrospective observational study PDF
(Rus)
Postolov M., Suvorov V., Kravets A.
卷 24, 编号 4 (2022) Disability-Adjusted Life Year (DALY) assessment and economic damage from premature death of cervical uterine and ovarian cancers in the Tomsk Region PDF
(Rus)
Zhuikova L., Ananina O., Sirotina A., Pikalova L., Fokin V., Kononova G.
卷 25, 编号 4 (2023) Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] PDF
(Rus)
Yudina E.
卷 3, 编号 4 (2001) Otsenka toksichnosti protivoopukholevogo preparata gemtsitabina (GEM)
Mamedov F., Narimanov M., Bazin I., Efimov O., Zharkov S., Tryakin A., Tyulyandin S., Garin A.
卷 14, 编号 2 (2012) Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progressiya opukholevogo protsessa posle khimioterapii taksanami
Gafanov R., Ivanov S., Fastovets S., Isaev T.
卷 26, 编号 3 (2024) Evaluation of the effectiveness of hematopoietic blood stem cell mobilization using empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases: the experience of several centers in the Russian Federation. A retrospective study PDF
(Rus)
Nesterova E., Mangasarova J., Bagova M., Fastova E., Magomedova A., Margolin O., Gorenkova L., Abdurashidova R., Galtseva I., Nakastoev I., Galuzyak V., Baiteryakova O., Shcherbakova A., Telyashov M., Spitsyn V., Sukhorukov D., Gemdzhian E., Zvonkov E., Petrova G., Sarzhevskiy V., Shorokhov N., Voloshin S., Linnikov S., Drozd M., Simashova P., Pop V., Rukavitsyn O., Davydova N., Arushanyan M.
卷 11, 编号 3 (2009) Otsenka effektivnostii bezopasnosti fotemustinav monorezhime i v kombinatsii s proizvodnymi platiny(karboplatinom ili tsisplatinom) pri lechenii disseminirovannoy melanomy
Konstantinova M., Savkova R., Demidov L., Gorbunova V., Kharkevich G., Antimonik N., Merkulov V., Simanovich E., Ral'chenko K., Sbrodov O.
卷 14, 编号 3 (2012) Pazopanib v lechenii rasprostranennogo pochechno-kletochnogo raka (klinicheskiy sluchay)
Savkov R.
卷 3, 编号 4 (2001) Paklitaksel (taksol): novye vozmozhnosti. Ezhenedel'nyy rezhim vvedeniya
Voznyy E.
卷 17, 编号 3 (2015) Pamyati Gianni Bonadonna
- -.
卷 12, 编号 3 (2010) Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti
Artamonova E.
卷 4, 编号 4 (2002) Parametry serdechno-dykhatel'nogo sinkhronizma i prognoz razvitiya onkologicheskogo zabolevaniya
Arkad'eva T., Ostrizhnaya N.
卷 15, 编号 1 (2013) Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients
Romanenko N.
卷 25, 编号 4 (2023) Patient resource to improve the effectiveness of oncological care for the population PDF
(Rus)
Kozlov V., Samsonov I., Mushnikov D.
卷 8, 编号 2 (2006) Pemetreksed (alimta)
Tyulyandin S.
卷 22, 编号 2 (2020) First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice PDF
(Rus)
Babicheva L., Poddubnaya I.
卷 10, 编号 3 (2008) Pervichnaya mediastinal'nayaV-krupnokletochnaya limfoma: diagnostika, klinicheskaya kartina i lechenie
Tumyan G., Kovrigina A., Kichigina M., Sorokin E., Bykov D., Kondrat'eva T., Probatova N., Trofimova O., Kolomeytsev O., Poddubnaya I., Tupitsyn N., Larionova V., Osmanov D.
卷 25, 编号 3 (2023) Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] PDF
(Rus)
Melnikov V.
601 - 750 的 1398 信息 << < 1 2 3 4 5 6 7 8 9 10 > >> 

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».